BioInfra Co.,Ltd.

Offers cancer screening blood tests and provides CRO services to the pharmaceutical industry.

199730 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 경기도 용인시 기흥구 흥덕중앙로 120 4층, 5층, 용인시
Website:: http://bioinfra.co.kr/?lang=en
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioInfra Co., Ltd. is a global healthcare and biotechnology company focused on advancing human health through innovative solutions for disease prevention and treatment. The company's core activities are centered on two primary business segments: diagnostics development and contract research organization (CRO) services. Its flagship product is a proprietary multi-biomarker blood test, a screening technology designed for the early detection of risk for eight major types of cancer. The company's CRO division provides comprehensive support to the pharmaceutical industry, offering services that include Phase 1 clinical trials, bioequivalence testing, immunoassays, and pharmaceutical quality inspections.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for BioInfra Co.,Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BioInfra Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for BioInfra Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
CHUGAI PHARMACEUTICAL CO., LTD. An R&D pharma leader in Japan creating innovative drugs via antibody engineering technology.	Japan	4519
Cinclus Pharma Holding AB Clinical-stage pharma developing a next-gen P-CAB drug for severe GERD patients.	Sweden	CINPHA
Circio Holding ASA Developing circular RNA vector tech and immunotherapies for gene and cell therapies.	Norway	CRNA
CJ Bioscience Develops microbiome therapeutics for oncology & IBD using an AI drug discovery platform.	South Korea	311690
CKD Bio Corp. Develops and manufactures probiotics & APIs using fermentation, also offering cGMP CMO services.	South Korea	063160
CMG Pharmaceutical Co., Ltd. Develops and manufactures prescription drugs, specializing in Oral Thin Film (OTF) technology.	South Korea	058820
co.don AG Develops personalized cartilage cell transplants for minimally invasive joint repair.	Germany	CNW
Compugen Ltd. Uses AI to discover and develop novel antibody immunotherapies for hard-to-treat cancers.	Israel	CGEN
CORESTEMCHEMON Inc. Develops stem cell therapies & provides preclinical CRO services to pharma & biotech.	South Korea	166480
Corline Biomedical AB Develops heparin-based coatings for medical device biocompatibility and regenerative medicine.	Sweden	CLBIO